CVS Health (CVS 0.50%) is a stock that's been struggling badly for multiple years and is coming off a brutal performance in 2024, when its shares nose-dived by 43%.Investors may have gotten lured into its low, attractive valuation or bought it for its high-yielding dividend, only to end up disappointed later on. The healthcare company, despite its broad diversification, hasn't provided investors with much safety at all; if you had held the stock for the past three years, your investment would have lost more ...